Somnics is featured at the WSGR Medtech Conference as one of the five MTI Vision Award finalists.
Somnics has made it to the final! It’s humbling to realize that so many of our peers from an incredible pool of companies voted for...
top of page
Sleep well.
Wherever you are.
A Novel Treatment for Obstructive Sleep Apnea Patients
Somnics develops in innovative technologies for the treatment of Obstructive Sleep Apnea.
Without masks and surgery, our iNAP® Sleep Therapy System provides a comfortable and discreet treatment for patients.
iNAP Features
Natural Breathing
iNAP allows you to breathe through the nose naturally without blowing air into the body while sleeping.
Compact and Travel-friendly
iNAP is incredibly light, small and compact. It fits in one hand and is therefore very travel-friendly.
Operation Without a Mask
iNAP works without having to wear cumbersome facial masks, belts or large hoses. iNAP is both easy-fitting and non-intrusive.
Discreet and Quiet
iNAP console is silent when negative pressure is reached and maintained, allowing you to sleep peacefully.
Superior Wearing Comfort
iNAP has a soft and flexible oral interface with thermal-memory material and one-size-fits-all design.
Portable and Rechargeable
iNAP is battery powered and ultra-portable for any situation, such as traveling by flight, camping, and mountaineering.
How it works
Patent Information
iNAP sleep therapy system and/or the use thereof in a method may be covered by one or more U.S. and/or foreign patents, including: US 7,918,222, US 8,567,406, US 8,616,208, US 9,138,342, US 9,387,117, US 9,339,620, US 10,080,855, US 10,149,782, US 10,149,783, US 10,159,595, US 10,166,140, US 8,122,889, US 8,656,922, US 8,667,970, US 9,241,825, US 9,655,768, US 8,505,540, US 9,610,190, US 8,074,656, US 8,122,890, US 8,701,672, US 8,387,620, US 9,387,118, US 9,387,119, US 10,117,773, US 8,402,973, US 8,573,223, US 8,979,823, US 9,549,795, US 9,101,495, US 9,375,541, US 9,763,759, US 9,483,792, US 15,376,368, EP 1862152, EP 2301490, EP 2347739, EP 2353555, EP 2868298, EP 2943170, EP 3095421, EP 2881090, EP 2209433, EP 2939634, EP 2605722, EP 0029004490001 RCD, EP 0029004490002 RCD, DE 2015121115024300, JP 5399534, JP 5727574, JP 5651488, JP 6002798, JP 6242914, JP 6346997, JP 6357573, JP 5404642, JP 5952817, JP 5944828, KR 10-1636436-0000, KR 10-1661639-0000, AU 2014205191, AU 2015399751, VN 3-2016-00928, VN 3-2016-00929, ID A00201601834, ID A00201601835, SG 30201602584Y, SG 30201602585X, TH 1602002134, TH 1602002135, IN 283925, IN 283926, CN 100506190, CN 102028574, CN 102133141, CN 102144946, CN 103989550, CN 103976814, CN 104000680, CN 104519841, CN 104540480, CN 104427958, CN 106170272, CN 205494125, CN 101917924, CN 103687568, CN 103140192, CN 103717181, and CN 201721828424.2 Other U.S. and foreign patent applications are pending. 睡眠呼吸中止
bottom of page